tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Twist Bioscience raises FY23 revenue view to $241M-$242M from $235M-$238M

Consensus $237.23M. Sees FY23 gross margin 36%. Sees FY23 capital expenditure $35M.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

See today’s best-performing stocks on TipRanks >>

Read More on TWST:

Disclaimer & DisclosureReport an Issue

1